Literature DB >> 25126376

Adipose-derived mesenchymal stromal/stem cells: An update on their phenotype in vivo and in vitro.

Patrick C Baer1.   

Abstract

Adipose tissue is a rich, ubiquitous and easily accessible source for multipotent stromal/stem cells and has, therefore, several advantages compared to other sources of mesenchymal stromal/stem cells. Several studies have tried to identify the origin of the stromal/stem cell population within adipose tissue in situ. This is a complicated attempt because no marker has currently been described which unambiguously identifies native adipose-derived stromal/stem cells (ASCs). Isolated and cultured ASCs are a non-uniform preparation consisting of several subsets of stem and precursor cells. Cultured ASCs are characterized by their expression of a panel of markers (and the absence of others), whereas their in vitro phenotype is dynamic. Some markers were expressed de novo during culture, the expression of some markers is lost. For a long time, CD34 expression was solely used to characterize haematopoietic stem and progenitor cells, but now it has become evident that it is also a potential marker to identify an ASC subpopulation in situ and after a short culture time. Nevertheless, long-term cultured ASCs do not express CD34, perhaps due to the artificial environment. This review gives an update of the recently published data on the origin and phenotype of ASCs both in vivo and in vitro. In addition, the composition of ASCs (or their subpopulations) seems to vary between different laboratories and preparations. This heterogeneity of ASC preparations may result from different reasons. One of the main problems in comparing results from different laboratories is the lack of a standardized isolation and culture protocol for ASCs. Since many aspects of ASCs, such as the differential potential or the current use in clinical trials, are fully described in other recent reviews, this review further updates the more basic research issues concerning ASCs' subpopulations, heterogeneity and culture standardization.

Entities:  

Keywords:  Adipose tissue; Adipose-derived stromal/stem cells; CD34; Heterogeneity; Mesenchymal stem cells; Phenotype; Subpopulation

Year:  2014        PMID: 25126376      PMCID: PMC4131268          DOI: 10.4252/wjsc.v6.i3.256

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  82 in total

1.  Preadipocyte number in omental and subcutaneous adipose tissue of obese individuals.

Authors:  Arjen H F Bakker; Francois M H Van Dielen; Jan Willem M Greve; Judit A Adam; Wim A Buurman
Journal:  Obes Res       Date:  2004-03

Review 2.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

3.  Perivascular multipotent progenitor cells in human organs.

Authors:  Mihaela Crisan; Chien-Wen Chen; Mirko Corselli; Gabriella Andriolo; Lorenza Lazzari; Bruno Péault
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

4.  BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype.

Authors:  S Kaiser; B Hackanson; M Follo; A Mehlhorn; K Geiger; G Ihorst; U Kapp
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

Review 5.  Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches.

Authors:  Andrea Augello; Tobias B Kurth; Cosimo De Bari
Journal:  Eur Cell Mater       Date:  2010-09-01       Impact factor: 3.942

6.  Human adipose tissue is a source of multipotent stem cells.

Authors:  Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

7.  Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM.

Authors:  I Müller; S Kordowich; C Holzwarth; C Spano; G Isensee; A Staiber; S Viebahn; F Gieseke; H Langer; M P Gawaz; E M Horwitz; P Conte; R Handgretinger; M Dominici
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

8.  Culture effects of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) on cryopreserved human adipose-derived stromal/stem cell proliferation and adipogenesis.

Authors:  Teddi L Hebert; Xiying Wu; Gang Yu; Brian C Goh; Yuan-Di C Halvorsen; Zhong Wang; Cedric Moro; Jeffrey M Gimble
Journal:  J Tissue Eng Regen Med       Date:  2009-10       Impact factor: 3.963

9.  Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT).

Authors:  Philippe Bourin; Bruce A Bunnell; Louis Casteilla; Massimo Dominici; Adam J Katz; Keith L March; Heinz Redl; J Peter Rubin; Kotaro Yoshimura; Jeffrey M Gimble
Journal:  Cytotherapy       Date:  2013-04-06       Impact factor: 5.414

10.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

View more
  64 in total

Review 1.  Adipose Tissue-Derived Stem Cells for the Treatment of Erectile Dysfunction.

Authors:  Ahmet Gokce; Taylor C Peak; Asim B Abdel-Mageed; Wayne J Hellstrom
Journal:  Curr Urol Rep       Date:  2016-02       Impact factor: 3.092

2.  Identification of the ectoenzyme CD38 as a marker of committed preadipocytes.

Authors:  A Carrière; Y Jeanson; J-A Côté; C Dromard; A Galinier; S Menzel; C Barreau; S Dupuis-Coronas; E Arnaud; A Girousse; V Cuminetti; J Paupert; B Cousin; C Sengenes; F Koch-Nolte; A Tchernof; L Casteilla
Journal:  Int J Obes (Lond)       Date:  2017-06-14       Impact factor: 5.095

Review 3.  Systems biology approach to developing S(2)RM-based "systems therapeutics" and naturally induced pluripotent stem cells.

Authors:  Greg Maguire; Peter Friedman
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

Review 4.  Role of liver progenitors in liver regeneration.

Authors:  Jan Best; Paul Manka; Wing-Kin Syn; Laurent Dollé; Leo A van Grunsven; Ali Canbay
Journal:  Hepatobiliary Surg Nutr       Date:  2015-02       Impact factor: 7.293

5.  Evaluation of adipose-derived stromal vascular fraction from the lateral tailhead, inguinal region, and mesentery of horses.

Authors:  Garrett L Metcalf; Scott R McClure; Jesse M Hostetter; Rudy F Martinez; Chong Wang
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

6.  TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation.

Authors:  Jan-Bernd Funcke; Verena Zoller; Muad Abd El Hay; Klaus-Michael Debatin; Martin Wabitsch; Pamela Fischer-Posovszky
Journal:  FASEB J       Date:  2015-04-09       Impact factor: 5.191

7.  Aldehyde Dehydrogenase Activity in Adipose Tissue: Isolation and Gene Expression Profile of Distinct Sub-population of Mesenchymal Stromal Cells.

Authors:  Mehdi Najar; Emerence Crompot; Leo A van Grunsven; Laurent Dollé; Laurence Lagneaux
Journal:  Stem Cell Rev Rep       Date:  2018-08       Impact factor: 5.739

Review 8.  A New Chapter for Mesenchymal Stem Cells: Decellularized Extracellular Matrices.

Authors:  Yagiz Anasiz; Riza Koksal Ozgul; Duygu Uckan-Cetinkaya
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

Review 9.  Stem cell therapy in intracerebral hemorrhage rat model.

Authors:  Marcos F Cordeiro; Ana P Horn
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

10.  Vitronectin-Based, Biomimetic Encapsulating Hydrogel Scaffolds Support Adipogenesis of Adipose Stem Cells.

Authors:  Tracy N Clevenger; Cassidy R Hinman; Rebekah K Ashley Rubin; Kate Smither; Daniel J Burke; Craig J Hawker; Darin Messina; Dennis Van Epps; Dennis O Clegg
Journal:  Tissue Eng Part A       Date:  2016-03-31       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.